Marketing-authorisation holder · Netherlands
Eli Lilly Nederland B.V.
345 medicines in 5 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Netherlands
345 medicines in 5 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 345
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABASAGLARSoluzione iniettabile | Insulin glargine | Italy | Authorised | |
| ABASAGLAR 100 E/ml, oplossing voor injectie in een patroonOplossing voor injectie | Insulin glargine | Netherlands | Authorised | 2014 |
| ABASAGLAR 100 E/ml, oplossing voor injectie in een voorgevulde penOplossing voor injectie | Insulin glargine | Netherlands | Authorised | 2014 |
| ABASAGLAR 100 UNIDADES/ML KWIKPEN SOLUCION INYECTABLE EN PLUMA PRECARGADA100 u · Solución inyectable en pluma precargada | Insulin glargine | Spain | Marketed | 2016 |
| Abasaglar (previously Abasria) | Insulin glargine | EU (EMA) | Authorised | 2014 |
| ADCIRCACompressa rivestita con film | Tadalafil | Italy | Authorised | |
| Adcirca 2 mg/ml orale suspensieSuspensie voor oraal gebruik | Tadalafil | Netherlands | Authorised | 2023 |
| ADCIRCA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Tadalafil | Spain | Marketed | 2010 |
| ADCIRCA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Tadalafil | Spain | Authorised | 2010 |
| Adcirca 20 mg, filmomhulde tablettenFilmomhulde tablet | Tadalafil | Netherlands | Authorised | 2008 |
| Adcirca (previously Tadalafil Lilly) | Tadalafil | EU (EMA) | Authorised | 2008 |
| Alimta | Pemetrexed | EU (EMA) | Authorised | 2004 |
| ALIMTAPolvere per concentrato per soluzione per infusione | Pemetrexed | Italy | Authorised | |
| Alimta 100 mg poeder voor concentraat voor oplossing voor intraveneuze infusiePoeder voor concentraat voor oplossing voor infusie | Pemetrexed | Netherlands | Authorised | 2007 |
| ALIMTA 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION100 mg · Polvo para concentrado para solución para perfusión | Pemetrexed | Spain | Marketed | 2008 |
| Alimta 500 mg, poeder voor concentraat voor oplossing voor intraveneuze infusiePoeder voor oplossing voor injectie | Pemetrexed | Netherlands | Authorised | 2004 |
| ALIMTA 500 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION500 mg · Polvo para concentrado para solución para perfusión | Pemetrexed | Spain | Marketed | 2004 |
| ALIMTA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION500 mg · Polvo para concentrado para solución para perfusión | Pemetrexed | Spain | Authorised | 2019 |
| AMYVIDSoluzione iniettabile | Florbetapir (18f) | Italy | Authorised | |
| Amyvid | Florbetapir (18f) | EU (EMA) | Authorised | 2013 |
| AMYVID 1.900 MBq/ml solucion inyectable1900 megabecquerelio · Solución inyectable | Florbetapir (18f) | Spain | Authorised | 2013 |
| Amyvid 1900 MBq/ml, oplossing voor injectieOplossing voor injectie | Florbetapir (18f) | Netherlands | Authorised | 2013 |
| AMYVID 1900MBQ/ML solucion inyectable1900 megabecquerelio · Solución inyectable | Florbetapir (18f) | Spain | Authorised | 2014 |
| Amyvid 800 MBq/ml, oplossing voor injectieOplossing voor injectie | Florbetapir (18f) | Netherlands | Authorised | 2013 |
| AMYVID 800 MBq/ml solucion inyectable800 megabecquerelio · Solución inyectable | Florbetapir (18f) | Spain | Authorised | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 140 | 137 | 3 | CompaniesAll medicines |
| Netherlands | 111 | 111 | 0 | CompaniesAll medicines |
| Romania | 36 | 0 | 36 | CompaniesAll medicines |
| European Union (EMA) | 33 | 27 | 6 | CompaniesAll medicines |
| Italy | 25 | 25 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.